CDH3 and cancer: P-cadherin is overexpressed in more than 50% of triple-negative breast cancer and is significantly associated with poor patient survival [7, 26, 27], showing a key role in some acquired cancer hallmarks, such as increased cell migration, invasion, as well as tumorigenic and metastatic capacity in breast cancer models [9, 11].